We are delighted to welcome you to the inaugural EUnetCCC Educational Seminar
As precision cancer care continues to advance across Europe, the establishment of robust professional networks and collaborative initiatives has become increasingly essential. This seminar launches a new EUnetCCC annual series dedicated to connecting and strengthening the multidisciplinary community engaged in precision cancer diagnostics, including molecular biologists, bioinformaticians, clinical researchers, oncologists, and other healthcare professionals.
This year’s seminar "Advancing Precision Oncology Through Molecular Tumour Boards" highlights the crucial role of molecular tumour boards in expanding access to precision cancer medicine. Molecular Tumour Boards bring together diverse expertise and cutting-edge molecular diagnostics to translate complex molecular data into actionable clinical decisions, ultimately improving outcomes for cancer patients.
Through a blend of expert lectures, interactive sessions and panel discussions, participants will gain practical insights into the functioning of Molecular Tumour Boards and the latest advancements in their implementation and clinical impact.
The seminar is designed not only as a learning experience but also as a vibrant networking platform, offering opportunities to engage with peers, share knowledge, and build collaborations.
Enjoy full access to the event at absolutely no cost! While attendance is free, participants will need to cover their own travel and accommodation. Hotel recommendations and a rebate code will be provided soon. Join us at Vall d’Hebron in Barcelona to be part of a dynamic and growing network dedicated to shaping the future of precision oncology and improving patient care across Europe
Organising Committee
Gro Live Fagereng
Oslo University Hospital CCC
Divya Tallapragada
Oslo University Hospital CCC
Philippa Druce
Oslo University Hospital CCC
Ana Bosch Campos
Skåne University Hospital CCC
Anders Edsjö
Skane University Hospital CCC & Lund University
Ana Carneiro
Skane University Hospital CCC & Lund University